Bright Minds Biosciences (DRUG) Common Equity (2022 - 2026)

For the quarter ending Q1 2026, Common Equity changed N/A year-over-year to $225.0 million, compared with a TTM value of $225.0 million through Mar 2026, changed N/A, and an annual FY2025 reading of $59.6 million, up 1368.96% over the prior year.

Bright Minds Biosciences (DRUG) has disclosed Common Equity for 5 consecutive years, with $225.0 million as the latest value for Q1 2026.

  • Common Equity reached $225.0 million in Q1 2026 per DRUG's latest filing, up from $59.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $225.0 million in Q1 2026 and bottomed at $4.1 million in Q3 2024.
  • Average Common Equity over 5 years is $60.3 million, with a median of $8.1 million recorded in 2022.
  • Year-over-year, Common Equity tumbled 39.11% in 2023 and then skyrocketed 1368.96% in 2025.
  • Bright Minds Biosciences' Common Equity stood at $8.1 million in 2022, then plummeted by 39.11% to $4.9 million in 2023, then dropped by 17.54% to $4.1 million in 2024, then soared by 1368.96% to $59.6 million in 2025, then surged by 277.38% to $225.0 million in 2026.
  • Per Business Quant, the three most recent readings for DRUG's Common Equity are $225.0 million (Q1 2026), $59.6 million (Q3 2025), and $4.1 million (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.42 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 35.63 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.36 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.42 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 13.21 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1.08 Bn
10 Bright Minds Biosciences 464.72 Mn 405.19 Mn - 224.98 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 224.98 Mn
Sep 30, 2025 59.62 Mn
Sep 30, 2024 4.06 Mn
Sep 30, 2023 4.92 Mn
Sep 30, 2022 8.08 Mn